comm-acq pneumonie - Mycoplasma
Advices
| Priority | Medication | Remarks |
|---|---|---|
|
Priority: 1st choice |
Medication: azitromycine po 500mg 1dd 5 days |
Remarks:
|
|
Priority: 1st choice |
Medication: doxycycline po 200mg 1dd followed by
doxycycline po 100mg 1dd |
Remarks:
|
| Priority | Medication | Remarks |
|---|---|---|
|
Medication: doxycycline iv 200mg 1dd 1 day followed by
doxycycline iv 100mg 1dd |
Remarks:
|
| Priority | Medication | Remarks |
|---|---|---|
|
Medication: levofloxacine iv loading dose 1000mg, 500mg 2dd 7 to 14 days |
Remarks:
|
Sources
- Link naar UMCG: CAP protocol
-
Pubmed.gov publication # 27446015
Pereyre S, Goret J and Bébéar C (2016) Mycoplasma pneumoniae: Current Knowledge on Macrolide Resistance and Treatment. Front. Microbiol. 7:974. doi: 10.3389/fmicb.2016.00974
- CAP/2016 SWAB
-
Pubmed.gov publication # 31573350
Metlay JP, Waterer GW, Long AC, Anzueto A, Brozek J, Crothers K, Cooley LA, Dean NC, Fine MJ, Flanders SA, Griffin MR, Metersky ML, Musher DM, Restrepo MI, Whitney CG. Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Crit Care Med. 2019 Oct 1;200(7):e45-e67. doi: 10.1164/rccm.201908-1581ST. PMID: 31573350; PMCID: PMC6812437.
Antimicrobial resources
The following antimicrobial agents have been used in these recommendations:
External antimicrobial resources
Menu position
Metadata
Swab vid: G-218331.7
Updated: 11/30/2023 - 12:37
Status: Published